Latest News

CLINICAL CASES IN NEUROLOGY – A 45 y.o. woman with worsening symptoms

 

Click here to complete the interactive survey.
Submit your responses anonymously to be able to view the aggregate results of the poll.

A.L. is a 45-year-old woman who works as an office administrator. She was diagnosed with MS five years ago. Her initial presentation was left optic neuritis that recovered with high-dose corticosteroids. MRI demonstrated lesions in the periventricular area and at C3. There were five OCBs in the CSF not present in serum. She was started on teriflunomide 14 mg/day as she was concerned about being immunosuppressed and said she preferred an oral therapy. Read More

MSToronto 2026 Highlights – Friday, October 23, 2026

 

Thursday Edition
Wednesday Edition

The 10th Joint meeting of the Americas and European Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS-ECTRIMS)

The following summarizes some of the highlights from Day 3 of MSToronto 2026.

New McDonald criteria increase diagnostic yield
First-line use of anti-CD20 agents: 2 studies
Do GLP-1 agonists have neuroprotective effects?
Obexelimab efficacy and safety
Ofatumumab vs. tocilizumab in MOGAD
Does EBV reactivation trigger MS relapses?
METEOROID trial of satralizumab in MOGAD
Clinical tip of the day
Read More

MSToronto 2026 Highlights – Thursday, October 22, 2026

 

Friday Edition
Wednesday Edition

The 10th Joint meeting of the Americas and European Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS-ECTRIMS)

The following summarizes some of the highlights from Day 2 of MSToronto 2026.

DOT-MS discontinuation study
OPERETTA 2 results for ocrelizumab in POMS
PIRA in early- and late-onset MS
Impact of anti-CD20 on PIRA
Low rate of postpartum relapses with anti-CD20 therapy
Does EBV seronegativity preclude MS diagnosis?
Update on FENhance trials of fenebrutinib
Clinical tip of the day
Read More